Frankie Siy, MD | |
2186 Eastex Fwy, Beaumont, TX 77703-4969 | |
(409) 899-4699 | |
Not Available |
Full Name | Frankie Siy |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 2186 Eastex Fwy, Beaumont, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093845901 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | F2012 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Frankie Siy, MD 2186 Eastex Fwy, Beaumont, TX 77703-4969 Ph: (409) 899-4699 | Frankie Siy, MD 2186 Eastex Fwy, Beaumont, TX 77703-4969 Ph: (409) 899-4699 |
News Archive
University at Buffalo neuroscience researchers conducting basic research on ion channels have demonstrated a process that could have a profound therapeutic impact on pain.
A new study suggests that echocardiography be included as part of screenings to help identify student athletes with heart problems that could lead to sudden death.
The Lancet published a significant development for TB diagnostics yesterday with concrete and encouraging study outcomes on the effectiveness of the new Xpert MTB/RIF test for TB and rifampicin resistance in realistic health care field conditions. One of the authors, Prof. Mark Nicol of the University of Cape Town (South Africa) who contributed to this study, is an EDCTP Senior Fellow. The article demonstrates that the test can effectively be used in low-resource settings to simplify early and accurate diagnosis of patients. The potential impact is a reduction in the morbidity associated with diagnostic delay, dropout and mistreatment. The article has appeared online on 19 April 2011 and will be published in volume 377 on 30 April 2011.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Cetirizine Hydrochloride Oral Solution, 1 mg/mL.
Quincy Bioscience, a research-based biotechnology company, announced the issuance of United States patent No.7,671,015. The patent covers the use of aequorin-containing compounds for the purpose of preventing and alleviating symptoms and disorders related to calcium imbalance.
› Verified 1 days ago
Dr. Lois M Miller, D.O. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3150 Medical Center Dr, Ste 1, Beaumont, TX 77701 Phone: 409-835-0505 Fax: 409-835-3700 | |
Nikole Leigh Eaves, DPT, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3050 Dowlen Rd Ste L, Beaumont, TX 77706 Phone: 409-861-4606 Fax: 409-861-4608 | |
Krystal Jean Morrell, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3560 Delaware, Suite 901, Beaumont, TX 77706 Phone: 409-898-3900 Fax: 409-898-3901 | |
Dr. Juan Elias Davila, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3650 Laurel St, Beaumont, TX 77707 Phone: 409-838-0346 | |
Leslie M. Bishop, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3070 College St, #406, Beaumont, TX 77701 Phone: 512-275-3700 | |
Dr. Linda C Smith, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 85 Ih 10 N Ste 202, Beaumont, TX 77707 Phone: 409-835-0505 Fax: 409-835-3700 |